-
Lilly's Trial Studying Higher Doses of Trulicity? (dulaglutide) Meets Primary Endpoint
americanpharmaceuticalreview
June 27, 2019
Eli Lilly and Company's trial studying higher investigational doses of Trulicity? (dulaglutide) met its primary efficacy endpoint of superiority, significantly reducing A1C from baseline in people with type 2 diabetes, compared to once-weekly?Trulicity?1.
-
Diabetes Outcomes Similar Regardless of Primary Provider
drugs
June 26, 2019
Diabetes Outcomes Similar Regardless of Primary Provider。
-
Job cuts limit cardiovascular and diabetes research and development
europeanpharmaceuticalreview
June 26, 2019
Pharmaceutical company, Sanofi, will eliminate jobs in France and Germany and end new in-house cardiology research programmes.
-
Global diabetes drug market expected to rise 3.6 percent
europeanpharmaceuticalreview
June 26, 2019
A new report predicts that the global diabetes drug market will rise to US$58.4 billion by 2025.
-
Anxiety With Type 2 Diabetes Tied to High-Cost Health Care Use
drugs
June 25, 2019
Anxiety With Type 2 Diabetes Tied to High-Cost Health Care Use.
-
Risk Factors ID'd for Atrial Fibrillation With Type 1 Diabetes
drugs
June 21, 2019
Risk Factors ID'd for Atrial Fibrillation With Type 1 Diabetes.
-
Type 2 diabetes treatment approved for children and adolescents
europeanpharmaceuticalreview
June 20, 2019
The FDA has approved an injection for use in patients aged 10-17 to treat type 2 diabetes.
-
FDA Approves Victoza Injection for Children 10 Years and Older with Type 2 Diabetes
drugs
June 19, 2019
FDA Approves Victoza Injection for Children 10 Years and Older with Type 2 Diabetes.
-
FDA Approves Victoza (liraglutide) for the Treatment of Pediatric Patients 10 Years or Older with Type 2 Diabetes
drugs
June 18, 2019
FDA Approves Victoza (liraglutide) for the Treatment of Pediatric Patients 10 Years or Older with Type 2 Diabetes.
-
Common Infant Rotavirus Vaccine May Also Shield Kids From Type 1 Diabetes
drugs
June 17, 2019
Common Infant Rotavirus Vaccine May Also Shield Kids From Type 1 Diabetes.